Blog / Archives
Rayno Life Science Portfolio Racks-Up More Gains: REGN, RGDX, SRLS
Who Does Not Know About the Bull Market in Biotech Stocks? The bull market in life science stocks gathered momentum today as the IBB rallied 2.34% (up 16.6% YTD) approaching its all time high of...
Response Genetics Raises $7.5M at $1.50 with New CEO
Early Player in Genetic Testing and Personalized Medicine Reloads RGDX Stock Trades Up 36% on Volume of 105k Shares at $1.60 Response Genetics (RGDX) announced today that it has entered purchase...
Biopharma Market Re-Ignited by News and NASDAQ Strength
The IBB hit another new high today at $118.85 as the biotech bull market rolls on. Our index of biopharmaceutical stocks were up 4% at one time propelled by Medivation (MDVN $67.67) up 22% on...
Rayno Biopharmaceuticals Portfolio 2/09/09-1/27/12
Rayno Life Science Biopharmaceutical Picks Beat All Sector Averages Life Science Market Hits 10 Year High Tracked by IBB ($115.51), and Up 46% Over 5 years Highlights of Rayno Biopharma Portfolio...
Rayno Life Science Portfolio: Another Buyout- MITI Goes for $1.16B
M&A Trend Picks Up Steam The beat goes on as Amgen agrees to buy Micromet (MITI $10.95) for $1.16B.Micromet is focused on treatment of hematologic malignancies with its BiTE monoclonal antibody...
Roche Bid for Illumina (ILMN) Drives Biotech Sector to New Highs
M&A Theme Provides Underlying Bid to Market Roche Holding, the most diversified diagnostics and pharmaceutical Company with an aggressive leveraged strategy for the molecular basis of disease...
“January Effect” Traders: Take Some Profits
If you followed our trades from November /December you made at least 20% so why push it? The Rayno Life Science Portfolio is down 0.75% today in a choppy market. Our mid-cap biopharmaceutical index...
“January Effect” Rolls On with Biotech Stocks Up Over 1%, 9.3% MTD
Seems a Bit Frothy Large and mid-cap biopharmaceutical stocks continued to surge today with the bellwether ETF IBB ($114) hitting one year highs of $114.15 today. Many of our recent focus picks also...
Trends from the JPMorgan Healthcare Conference 2012
Healthcare: Broad Trends and Business Concepts for 2012 Last year we published an overview of trends for the 2011 JPMorgan Conference. Here is a very brief review from this year's Conference: The...
“January Effect” Rally: A Cliched Trade That Really Works
You read about it every year, and always there are skeptics, but in Q4 2011 to Q 2012 the "January effect " rally for small cap and life science stocks were big winners. Why does this happen? Not so...